The ENCHANT-1 trial (NCT01677455): An open label multicenter phase 2 proof of concept study evaluating first line ganetespib monotherapy in women with metastatic HER2 positive or triple negative obreast cancer (TNBC)
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | AWADA, A. | |
dc.contributor.author | SPECTOR, N. | |
dc.contributor.author | EL-HARIRY, I. | |
dc.contributor.author | RODRIGUEZ, A. A. | |
dc.contributor.author | ERBAN, J. K. | |
dc.contributor.author | CORTES, J. | |
dc.contributor.author | GOMEZ, H. | |
dc.contributor.author | KONG, A. | |
dc.contributor.author | HICKISH, T. | |
dc.contributor.author | FEIN, L. | |
dc.contributor.author | VAHDAT, L. | |
dc.contributor.author | MACPHERSON, I. | |
dc.contributor.author | CANON, J-L | |
dc.contributor.author | MANSOOR, S. | |
dc.contributor.author | GIOVANNE, A. | |
dc.contributor.author | MCADAM, K. | |
dc.contributor.author | VUKOVIC, V. M. | |
dc.contributor.author | YALCIN, I. | |
dc.contributor.author | BRADLEY, R. | |
dc.contributor.author | PROIA, D. | |
dc.contributor.author | MANO, M. S. | |
dc.contributor.author | PEREZ, E. A. | |
dc.contributor.author | CAMERON, D. A. | |
dc.date.accessioned | 2015-11-11T16:27:45Z | |
dc.date.available | 2015-11-11T16:27:45Z | |
dc.date.issued | 2013 | |
dc.description.index | MEDLINE | |
dc.identifier.citation | CANCER RESEARCH, v.73, suppl.24, 2013 | |
dc.identifier.doi | 10.1158/0008-5472.SABCS13-P2-16-23 | |
dc.identifier.eissn | 1538-7445 | |
dc.identifier.issn | 0008-5472 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/12114 | |
dc.language.iso | eng | |
dc.publisher | AMER ASSOC CANCER RESEARCH | |
dc.relation.ispartof | Cancer Research | |
dc.rights | restrictedAccess | |
dc.rights.holder | Copyright AMER ASSOC CANCER RESEARCH | |
dc.subject.wos | Oncology | |
dc.title | The ENCHANT-1 trial (NCT01677455): An open label multicenter phase 2 proof of concept study evaluating first line ganetespib monotherapy in women with metastatic HER2 positive or triple negative obreast cancer (TNBC) | |
dc.type | conferenceObject | |
dc.type.category | meeting abstract | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.affiliation.country | Inglaterra | |
hcfmusp.affiliation.countryiso | gb | |
hcfmusp.author.external | CORTES, J.:Peterborough & Stamford Hosp NHS Fdn Trust, Peterborough, Cambs, England | |
hcfmusp.contributor.author-fmusphc | MAX SENNA MANO | |
hcfmusp.description.issue | suppl 24 | |
hcfmusp.description.volume | 73 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.wos | WOS:000209496901069 | |
hcfmusp.publisher.city | PHILADELPHIA | |
hcfmusp.publisher.country | USA | |
relation.isAuthorOfPublication | 1541ce2f-dafd-4094-b650-ef95fa7da1e3 | |
relation.isAuthorOfPublication.latestForDiscovery | 1541ce2f-dafd-4094-b650-ef95fa7da1e3 |